| scholarly article | Q13442814 |
| P50 | author | Owen J T McCarty | Q87022376 |
| Jonathan R Lindner | Q89706631 | ||
| Philip G de Groot | Q115215601 | ||
| P2093 | author name string | Yan Zhao | |
| Douglas R. Keene | |||
| Todd Belcik | |||
| Yue Qi | |||
| Aris Xie | |||
| Daogang Zha | |||
| Weihui Shentu | |||
| Chad Carr | |||
| Garth W. Tormoen | |||
| Robert B. Conley | |||
| P2860 | cites work | The molecular mechanisms of the thrombotic complications of atherosclerosis | Q24656816 |
| Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes | Q30304696 | ||
| Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin | Q30308172 | ||
| Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. | Q30310323 | ||
| Multimodality cardiovascular molecular imaging, Part II | Q30438207 | ||
| Automated quantification of the spatial extent of perfusion defects and viability on myocardial contrast echocardiography | Q30440033 | ||
| Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. | Q30483148 | ||
| Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease | Q30492960 | ||
| ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions | Q33344837 | ||
| Platelets have more than one binding site for von Willebrand factor | Q33821754 | ||
| Platelets in atherothrombosis | Q34986345 | ||
| Platelet adhesion: a game of catch and release | Q37251725 | ||
| Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia | Q44010401 | ||
| A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. | Q46778536 | ||
| Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients | Q47809536 | ||
| Intravascular ultrasound molecular imaging of atheroma components in vivo | Q47972229 | ||
| Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist. | Q50877980 | ||
| Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction | Q80086704 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phenotype | Q104053 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 947-955 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | JACC: Cardiovascular Imaging | Q15816252 |
| P1476 | title | Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotype | |
| Molecular Imaging of Activated von Willebrand Factor to Detect High-Risk Atherosclerotic Phenotype | |||
| P478 | volume | 3 |
| Q51732018 | Accelerated Clearance of Ultrasound Contrast Agents Containing Polyethylene Glycol is Associated with the Generation of Anti-Polyethylene Glycol Antibodies. |
| Q38003373 | Cardiovascular devices and platelet interactions: understanding the role of injury, flow, and cellular responses |
| Q27021416 | Cardiovascular molecular imaging with contrast ultrasound: principles and applications. |
| Q30408017 | Detection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets |
| Q89551292 | Effect of Model Thrombus Volume and Elastic Modulus on Magnetomotive Ultrasound Signal Under Pulsatile Flow |
| Q44156689 | Ex vivoimaging of injured arteries in rabbits using fluorescence-labelled glycoprotein VI-Fc |
| Q30659684 | Flow-driven assembly of VWF fibres and webs in in vitro microvessels |
| Q30446090 | Future applications of contrast echocardiography |
| Q33427429 | High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion |
| Q35947472 | In vivo targeting of inflammation-associated myeloid-related protein 8/14 via gadolinium immunonanoparticles. |
| Q88984493 | Inflammation, von Willebrand factor, and ADAMTS13 |
| Q37592842 | Measurement science in the circulatory system. |
| Q27339951 | Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis |
| Q90667459 | Molecular Imaging of VWF (von Willebrand Factor) and Platelet Adhesion in Postischemic Impaired Microvascular Reflow |
| Q28070313 | Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models |
| Q30442045 | Molecular imaging in cardiovascular disease: Which methods, which diseases? |
| Q30457844 | Molecular imaging of disease with targeted contrast ultrasound imaging |
| Q36617730 | Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. |
| Q36135602 | Molecular imaging of thrombus: technology in evolution |
| Q39125083 | Platelets and von Willebrand factor in atherogenesis |
| Q38145381 | Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease |
| Q92396778 | Seeing the Invisible-Ultrasound Molecular Imaging |
| Q27300813 | Thrombus-Targeted Theranostic Microbubbles: A New Technology towards Concurrent Rapid Ultrasound Diagnosis and Bleeding-free Fibrinolytic Treatment of Thrombosis |
| Q30455981 | Ultrasonic imaging of endothelial CD81 expression using CD81-targeted contrast agents in in vitro and in vivo studies |
| Q88083584 | Ultrasound Molecular Imaging of Atherosclerosis Using Small-Peptide Targeting Ligands Against Endothelial Markers of Inflammation and Oxidative Stress |
| Q28087550 | Ultrasound imaging for risk assessment in atherosclerosis |
| Q39208821 | Utility of microfluidic devices to study the platelet-endothelium interface |
Search more.